Dry eye disease (DED) is a frequently observed eye complaint, which has recently attracted
considerable research interest. Conventional therapy for DED involves the use of artificial …

Topical drug delivery is one of the most challenging aspects of eye therapy. Eye drops are
the most prevalent drug form, especially for widely distributed anterior segment eye …

Low bioavailability of topically applied drugs remains a significant challenge for long-term
glaucoma therapy. To enhance drug delivery efficiency, we developed dendrimer gel …

Erythropoietin (EPO) is known for its neuroprotective and neuroregenerative properties. EPO
topical ocular administration has not been tested yet and its bioavailability could be …

The eye, a complex organ isolated from the systemic circulation, presents significant drug
delivery challenges owing to its protective mechanisms, such as the blood-retinal barrier …

Effective delivery of drug molecules to the target site is a challenging task. In the last decade,
several innovations in the drug delivery system (DDS) have tremendously improved the …

Our present series of experiments was to create a value-added formulation that has the
potential to exert a powerful and long-lasting antibacterial effect for use in ophthalmology …

Ocular drug delivery presents a unique set of challenges owing to the complex anatomy and
physiology of the eye. Processed excipients have emerged as crucial components in …

The human eye's intricate anatomical and physiological design necessitates tailored
approaches for managing ocular diseases. Recent advancements in ophthalmology …

Blindness affects more than 60 million people worldwide. Retinal disorders, including age-
related macular degeneration (AMD), diabetic retinopathy (DR), and glaucoma, are the …